Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparing Therapies for the Treatment of Severe Aplastic Anemia
This study has been completed.
Study NCT00001626   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: October 24, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Aplastic Anemia
Hematologic Disease
Additional conditions recognized in this trial
Anemia
Anemia, Aplastic
Hematologic Diseases
More general conditions related to this trial
Bone Marrow Diseases
Interventions listed in this trial
Cyclophosphamide & Cyclosporin A
Additional drug interventions recognized in this trial
Antilymphocyte Serum
Cyclophosphamide
Cyclosporine
Cyclosporins
More general drug interventions related to this trial
Alkylating Agents
Anti-Infective Agents
Antifungal Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antirheumatic Agents
Dermatologic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services